Shockwave Medical
$327.71
24H
Market Cap
Volume
Supply
Price Chart
About Shockwave Medical - SWAV
Shockwave Medical, Inc. is a medical device company that specializes in the development and commercialization of intravascular lithotripsy technology, which is designed to treat calcified plaque in cardiovascular disease with a minimally invasive approach. Their technology uses sonic pressure waves to safely break up calcified deposits in blood vessels, facilitating the treatment of arterial calcification and improving patient outcomes.
What are Shockwave Medical's core values and mission statement?
Shockwave Medical, Inc. is centered around developing and commercializing products that are designed to transform the way medical practitioners treat calcified cardiovascular disease. Their mission focuses on innovating breakthrough medical devices that enable or enhance less invasive treatments for atherosclerotic cardiovascular disease.
Who founded Shockwave Medical and when?
Shockwave Medical, Inc. was founded by Daniel Hawkins and John Adams in 2009.
Who leads Shockwave Medical?
As of the last available information, Doug Godshall is the CEO and President of Shockwave Medical, Inc.
Where is Shockwave Medical located, and what is its base country?
Shockwave Medical, Inc. is based in Santa Clara, California, United States.
On which exchanges is Shockwave Medical traded?
Shockwave Medical, Inc. is traded on the Nasdaq stock exchange under the ticker symbol SWAV.
Historical data
Shockwave Medical (SWAV) Price Live Data
The live price of Shockwave Medical (SWAV) is $327.71, with a trading volume of 981,854 in the last 24 hours. Wrapstocks updates the SWAV price in real-time. Shockwave Medical is up 0.06% in the last 24 hours. The company has a live market cap of $12,291,648,512.00 and a supply of 37,507,700 SWAV stocks.
Shockwave Medical (SWAV) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 7 hours and 57 minutes.
